The following submissions are in response to the following TGA consultation documents:
CMA submission to the Therapeutic
Goods Amendment (2016 Measures No. 1) Bill 2016 inquiry. - Click here to read the submission (3 March 2017)
Submission to the TGA
Consultation on the regulatory framework for advertising therapeutic goods (21
Submission to Department of Foreign Affairs and Trade on the Discussion Paper on Addressing Non-Tariff Measures (December 2016)
Submission to the Medicines Scheduling Secretariat: amendments to the Poisons Standard, rescheduling of melatonin, ACMS meeting November 2016 (1 September 2016)
Submission to the Productivity commission on Data Availability and Use (November 2016)
Submission to Department of Industry, Innovation and Science on the Review of the R&D Tax Incentive (October 2016)
Productivity Commission on its Issues Paper: Consumer Law Enforcement and Administration (30 August 2016)
Submission to the Structural Review of NHMRC’s Grant Program (25 August 2016)
Submission to Food Standards Australia New Zealand (FSANZ) on Proposal P1042 - Low THC hemp seeds as food (25 August 2016)
Submission to TGA Scheduling Committee: consideration of new ingredient - Kunzea ericoides (Kānuka) essential oil (8 August 2016)
Submission to Productivity Commission: Draft report on Australia’s Intellectual Property Arrangements (3 June 2016)
Submission to Scheduling Medicines: Proposed Amendments to the Poisons Standard Piper methysticum (Kava)(6 May 2016)
Submission to TGA on compositional guideline development for new ingredient approval - Grifola Frondosa (maitake mushroom) (11 April 2016)
CMA response to the TGA Complementary and OTC Medicines Branch Safety Review: Sanguinaria canadensis (18 April 2016)
CMA submission to TGA Complementary and OTC Medicines Branch: Business Process Reform for Complementary Medicines (18 April 206)
Submission to TGO 92 - Guidance Document consultation - Standard for the labels of non-prescription medicines - sections 9(2) and 9(3) (1 April 2016)
CMA Submission to New Zealand Ministry of Health: Natural Health Products Bill Consultation (4 March 2016)
CMA submission to the 2016/17 Federal pre-Budget Submission (January 2016)
TGA consultation on updates to the list of permissible ingredients: Therapeutic Goods (Permissible Ingredients) Determination No. 1 & 2 (2015-16)
CMA participation on the TGA- Industry Working Group on GMP (TIWGG) (2015-16)
CMA participation on the TGA-Industry Complementary Medicines Technical Working Group (CM-TWG) (2015-16)
CHC submission to the TGA in response to the Low Value Turnover (LVT) consultation (May 2014)
Submission on the Therapeutic Goods Administration Guidance on Release for Supply for Medicines Manufacturers (6 September 2013).
Submission on the TGA approach to disclosure of commercially confidential information ( CCI) (29 August 2013).
Submission on the TGA proposal for automatic adoption of new versions of the PIC/S Guide to Good Manufacturing Practice for Medicinal Products (12 August 2013).
Submission on the Australian Regulatory Guidelines for Complementary Medicines(ARGCM) Part D: Registered Complementary Medicines (22 July 2013).
Submission on the Regulation Impact Statement: Regulating the advertising of therapeutic goods to the general public (19 July 2013)
Submission on the International Harmonisation of Ingredient Names (10 July 2013).
Submission on the Review of Arrangements for the Scheduling of Medicines and Poisons (29 April 2013).
Submission on the Trans Tasman Early Warning System How the process will work in Australia and New Zealand (7 April 2013).
Submission on the Permitted (Coded) Indications for Listed Medicines consultation paper (15 March 2013).
Submission on the ANZTPA Discussion Paper 'Description of a possible joint regulatory scheme for therapeutic
products under ANZTPA' (21 February 2013).
Submission on the Australian Regulatory Guidelines for Complementary Medicines (ARGCM) Part B: Listed Medicines (18 February 2013).
Submission on the System of Australian Recalls Actions (SARA) Prototype Database (15 February 2013).
Submission on the Australian Regulatory Guidelines for Complementary Medicines (ARGCM) Part A: General Guidance (7 November 2012).
Submission on the revised draft guideline: Evidence required to support indications for Listed medicines (excluding sunscreens and disinfectants), version 2.0 August 2012. (22 October 2012).Submission on the TGA Standard (Coded) Indications Project - pre consultation phase. (7 September 2012)
Submission on the draft guideline: Evidence required to support indications for
Listed medicines (excluding sunscreens and disinfectants) (25 May 2012).
Industry combined Regulation Impact Data (Att. 5a)
Submission on MSM scheduling (19 January 2011)
The following submissions are in response to the following FSANZ consultation documents:
CMA submission to Food Standards Australia New Zealand P1030 Proposal Health Claims - Formulated Supplementary Sports Foods and Electrolyte Drinks
Submission on the Proposed Future Regulation of Nutritive Substances and Novel
Foods in the Australia New Zealand Food Standards Code (May 2012).
Submission on the Proposal P293 Nutrition, Health and Related Claims (30 March 2012)
Submission on the Proposal P242 Food for Special Medical Purposes (9 February 2011)
made to the Australian Codex Committee on Nutrition and Foods for Special
Dietary Uses on the Proposed Draft Revised Standard for Follow-Up Formula - November 2016
Submission on NZ Natural Health Product Bill Summary. The Complementary Healthcare Council provides a summary paper on the New Zealand Natural. Health Products Bill (Government Bill 324-1). Click here to read more.Submission addressing the Review of the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) (27 July 2012).
Submission to the NSW Government Manufacturing Industry Action Plan: Complementary Medicines (5 December 2011)
Submission on the Implmentation of Model Schedules for Commonwealth Serious Drug Offences (11 March 2011)
Submission on accreditation and registration standards for naturopathy and Western herbal medicine (31 January 2011)